Tigo, Merasol .
HRN: 13-38-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFTRIAXONE 1G (VIAL)
03/13/2024
03/19/2024
IV
2g
OD
CAP MR
Waiting Final Action